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ISSUES IN THE USE OF MAINTENANCE 
ELECTROCONVULSIVE THERAPY 
T.N.SRINIVASAN, T.R.SURESH, VASNTHA JAYARAM 
This case report on the use of Maintenance Electroconvulsive Therapy (ECT-M) presents certain 
observations and raises some issues in the use of the method. The report offers wider indication for 
ECT-M, including schizophrenia and bipolar disorders and younger patients. It raises the issues that 
die duration of use of ECT-M can be short rather than indefinite and that in the post ECT-M period, 
drug maintenance using the same drugs which were ineffective pre-ECT-M can be used effectively. The 
report presents those observations for further systematic study. The cost benefit advantage of the method 
and its relevance to the need for more frequent use in developing countries is illustrated 
Key words: maintenance ECT, non-depressive psychoses, short-term use, post-ECT-M drug therapy, 
economic advantage. 
INTRODUCTION 
The use Electroconvulsive Therapy (ECT) in the 
treatment of acute phases of major psychiatric dis-
orders is well known and its advantages over drugs 
in certain disorders like major depression and 
psychotic depression makes it the treatment of 
choice on some of those patients. However, follow-
ing ECT induced recovery clinicians resort to drugs 
than ECT for maintaining the remission. But one is 
coming to realize that the pharmacologic agents 
often fail to manage effectively the relapsing nature 
of most psychiatric illness due to several factors, the 
prominent of which are drug resistance, poor drug 
compliance, intolerable side effects and the cost of 
drug management. In the late 1980's Fink had called 
for a renewed research interest on use of ECT as 
maintenance treatment (Fink, 1987) and recent 
reports showed this method of treatment under new 
light (Decina et al, 1987; APA, 1990; Monroe, 
1991). 
In India, and possibly in other developing 
countries, ECT is used more frequently than in the 
west, probably due to different socioeconomic fac-
tors here. However, there is a striking lack of report 
on the use of ECT-M from developing countries like 
India though a national survey on the use of ECT by 
psychiatrists indicated that its use in India is not 
uncommon (Agarwal et al, 1992). 
This case report is based on our experience of 
using ECT-M at Sri Ramachandra Hospital in the 
past two years. Six cases are cited below to highlight 
the varied indications for use of ECT-M, the efficacy 
of the method and clinical and economic advantages 
over drug maintenance management and the issue of 
post ECT-M drug therapy. The term maintenance 
ECT (ECT-M) is used in this paper to mean its use 
for both the control of relapse (exacerbation of an 
ongoing episode) as well as recurrence (new episode 
following complete recovery) (Monroe, 1991). 
CASE REPORTS 
The table gives in brief, the details of the six 
patients. The clinical diagnosis was made using 
DSM m-R criteria. All the patients had initially 
responded well to ECT but subsequently had prob-
lem with drug maintenance regimens. ECT-M was 
started from the end of a course of regular ECT. 
Bilateral sinusoidal wave method of ECT was ap-
plied using cuff method to measure duration of the 
convulsion. Five received ECT at varying interval 
schedule (VIS-ECT), progressing from weekly (1st 
month) to fortnightly (2nd month) and subsequent 
monthly sessions. One received ECT at fixed inter-
val schedule (FIS-ECT), at monthly intervals. 
Informed consent was obtained from the patients 
and parents or spouses after the procedure and pos-
sible side effects were fully explained. The ECT-M 
was given for a period of 6 months to 2 years (This 
period of ECT-M was arbitrary for we lack informa-
tion on exactly bow long it should be given). The 
follow up after the last ECT varied from 8 months 
to 2 years. During the period of ECT-M all, except 
one, received low doses of medication (at least 50% 
lesser than the maintenance medication used before 
ECT-M). After the course of ECT-M, all the patients 
were maintained on drugs using lesser number of 
drugs and/or lesser and tolerable doses of the same 
drugs that were used before ECT-M. The type of 
drugs prescribed was subject to restriction by the 
cost and availability at the hospital. 
The psychiatric status and cognitive side effects 
were evaluated by standard clinical evaluation and 
quantified by using the Neuro Behavioral Rating 
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ECT-M Clinical Mails 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
Age 4 Sex 
52/F 
18/F 
26/M 
32/F 
24/F 
28/M 
Diagnosis 
MO 
BPD 
BPD 
PS 
MD 
PS 
Problem with 
drugs 
Cost 
Poor compliance 
Non response 
Cost 
Non response 
Cost 
Non response 
Noncompliance 
Side effect 
Relapses 
Side effect 
Poor symptom 
control 
Side effect 
Poor symptom 
control 
ECT-M 
Duration Follow-up 
14 months 
2 years 
lyear 
6 months 
8 months 
lyear 
lyear 
lyear 
2 years 
8 months 
1 year 
2 years 
Drugs 
during and 
after ECT-M 
Course 
during and 
after ECT-M 
Lower dose 
lmipramine(No Remission 
drug during ECT-M) 
Lower dose and 
lesser number 
antipsychotics 
Lower dose 
Haloperidol 
Lower dose 
Chlorpromazine 
Lower dose 
Imipramine 
Lower dose 
Chlorpromazine 
Less IP stay 
symptoms 
milder 
Remission 
Remission 
Remission 
Remission 
MD = Major Depression; BPD = Bipolar Disorder; PS = Paranoid Schizophrenia. 
Scale (Levin et al, 1987) and the Mini Mental State 
Examination (Folstein et aL 1975). The evaluation 
was done prior to each ECT and at least once in the 
interval between ECTs. There was no significant 
cognitive dysfunction in any of the patients. The 
acceptance of the method of ECT-M by the patient 
and the family posed no problems. 
The economic aspects of ECT-M showed distinct 
advantages of their treatment. For example, in the 
case nos. 1, 2 and 3, the expenses for treatment for 
the patient and the hospital amounted to about Rs. 
150 to Rs. 200 per month in the year preceding 
ECT-M. The application of one ECT costs only Rs. 
30 approximately and reduction in number of drugs 
and drug dosage saved 50-60% of the expenses. The 
steady productivity due to stable remission induced 
by ECT-M led to further improvement in the earning 
capacity of the patients, as in case nos. 3, 5 and 6. 
One of the cases is described below to bring out 
certain issues in the use of ECT-M. 
Mr S, was 28 years old, employed and unmarried. 
He has been under treatment and follow-up for 
paranoid type schizophrenia for the past 5 years. The 
general course of the illness, before starting ECT-M, 
had been one of repeated relapses with minimal but 
stable personality change in the intervals. The first 
episode of contact of 1 year duration was managed 
by use of drugs combined with ECT as an inpatient. 
ECT had been applied at this time because of his 
intolerance to higher dose of drugs and to shorten the 
period of hospitalization. Subsequent to this 
episode, he was continued on chlorpromazine which 
he tolerated better than other available drugs at a 
dosage of upto 200 mgms/day. During the next two 
years, he relapsed four times into an episode of 
illness which required an increase in drug dosage 
and a short course of ECT and brief hospitalization 
for two such episodes. Besides these episodes, he 
often experienced symptoms like insomnia and 
anxiety which were causing considerable distress. 
An increase in the dose of chlorpromazine for 
maintenance did produce clinical stability but the 
patient felt side effects like drowsiness and dry 
mouth which was interfering with his return to nor-
mal work. This loss of work capacity despite clinical 
remission was causing monetary difficulties for the 
patient. He was started on ECT-M at monthly inter-
vals given on weekend while on a minimal dose of 
chlorpromazine (100-150 mgms/day). ECT-M was 
given for twelve months and subsequently he was 
followed up for two years using only 
chlorpromazine at a dose of 100-150 mgms/day, 
which he tolerated well. The patient was in full and 
stable remission during the one year of ECT-M. This 
was maintained during the two year post ECT-M 
period. 
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DISCUSSION 
The majority of studies on ECT-M suggests its 
use mainly in depressive illness, especially 
psychotic depression. Early reports of its use in 
schizophrenia and schizoaffective psychosis have 
been disputed for the criteria of diagnosis used 
(Stevenson & Geoghegan, 1951; Hastings, 1961). 
Rigorous diagnostic criteria have been used in our 
cases, indicating the use of ECT-M in disorders 
others than depression. Monroe (1991), at the end of 
his review, cautioned that one should not conclude 
that the method is effective only in relapsing or 
psychotic depression or in the elderly who are 
medication intolerant based on reports made those 
far. Hastings (1961) had argued that ECT-M would 
be the rational choice for prophylaxis for bipolar 
disease given the episode nature of the disorder. The 
present report supports such notions and points out 
that the common characteristics which favor the use 
of ECT-M, not withstanding the diagnosis, are 
relapsing nature of illness (with or without return to 
complete normalcy) and a good response to ECT in 
the initial phase. The other common indications for 
ECT-M mentioned earlier (Decina et aL 1987 were 
also illustrated in our cases. The cost-benefit ad-
vantage of ECT-M over drug therapy has been clear-
ly experienced on our cases. In general, we found 
that there is at least a 3 to 4 fold decrease in cost with 
ECT-M to drugs. This advantage has impotent 
relevance to its practice under conditions like in 
India. 
The majority of experience with ECT-M suggests 
that it should be used more extensive than at present. 
More liberal use of ECT-M could be attended with 
some risks. Cognitive impairment, although normal-
ly shown to be transient and minimal, may be a 
greater issue when ECT is applied over months or 
even years, especially in the elderly. However, the 
advantages far outweigh the disturbing and some-
times more harmful side effects of long term use of 
drugs. The other risk is the inability to decide when 
one is over-treating the condition. Our observation 
suggests that the period of use of ECT-M need not 
be indefinite and that it can be used for short periods 
to stabilize remission and further maintenance is 
facilitated with low dosage drug therapy, using the 
same drug as used prior to ECT-M. However, as 
mentioned before, we do not yet have enough data 
to decide the duration of ECT-M course in given 
patient. The issue of post ECT drug maintenance has 
been addressed by Monroe (1991) who questioned 
the use of same drug for maintenance when the 
patient had been nonresponding to them prior to 
ECT. Devanand et al (1991) have reported that 
patients respond better to antidepressants of a class 
different from that used prior to ECT. Hence the 
effective ase of same drug post ECT-M in our cases 
needs explanation. We feel that this response ob-
served could be due to better compliance with drug 
intake by the patient who is clinically better stabi-
lized, improved tolerance of drugs by the patient 
and, lastly and most possibly that the disease process 
had become more amenable 'softened' to the same 
drug by the use of ECT-M. 
In conclusion, the case reports attempt to bring to 
focus the following issues which require systematic 
study. 
i) The use of ECT-M not only in depression but 
also in other major disorders with an episodic course 
and responsive to ECT and its use in younger sub-
jects in contrast to its use often reported in the 
elderly. 
ii) The course of ECT-M need not be indefinite 
and its use for a short time could facilitate further 
maintenance with drugs. 
iii) The use of drug maintenance following ECT-
M could involve the same type of drug and/or lesser 
amount of drugs than that used prior to ECT-M. 
iv) The distinct cost-benefit advantage of ECT-M 
over drugs, which is highly relevant to its more 
frequent use under economic constraints. 
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